Efficacy of Yoga Therapy for Migraine: Addressing Headache Frequency
In a meta-analysis, researchers examined the efficacy of yoga therapy as a treatment for patients with migraine.
Subject: Headache
Lidocaine Infusions Beneficial for Refractory Chronic Migraine
Lidocaine infusions seem beneficial for refractory chronic migraine.
FDA to Review Intranasal Zavegepant for Migraine Treatment
The NDA submission includes data from 2 pivotal studies that evaluated zavegepant in adults with at least a 1-year history of migraine and migraine attacks.
Sleep Restriction Decreases GABAergic Cortical Inhibition During Interictal Migraine Phase
Researchers sought to assess the short-term benefit and risk of ticagrelor with aspirin in patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack.
Genetic Analysis Suggests Coffee Intake Not Linked to Migraine
There seems to be no causal relationship between genetically predicted coffee consumption and risk for migraine.
FDA Delays Decision on Meloxicam/Rizatriptan Combination for Acute Migraine
AXS-07 is an oral agent that consists of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug, and rizatriptan, a 5-HT1B/1D agonist.
Migraine May Raise Risk for Burning Mouth Syndrome
Migraine is associated with an increased risk for burning mouth syndrome.
More Than 1 in 7 Have a Headache on Any Given Day
Headache disorders remain highly prevalent worldwide.
Monthly Erenumab Appears Safe, Effective for Chronic Migraine in Asian Patients
Presenting at the 2022 AAN Annual Meeting, researchers assessed the safety and efficacy of monthly erenumab among adult patients with chronic migraine with Asian ancestry.
Add-on Biofeedback Virtual Reality Tool Shows Promise for Chronic Migraine
Researchers sought to establish whether frequent use of a combined biofeedback-virtual reality device is associated with improvements in chronic migraine, especially in patients refractory to pharmacotherapy.
- Loading...
Loading...
Next post in Migraine & Headache
Loading... 
Loading...